Description
Brief data in regard to the innovative ideas and entrepreneurial spirit of seed and early stage medical device.
M2D2 New Venture Competition
Call for Applications - Important Information
The University of Massachusetts’ Medical Device Development Center (M2D2) is pleased to
launch the 4
th
Annual M2D2 New Venture Competition, an opportunity designed to showcase
the innovative ideas and entrepreneurial spirit of seed and early-stage medical device companies.
The M2D2 New Venture Competition Program is sponsored in partnership with Boston
Scientific, the Massachusetts Life Sciences Center, Mintz Levin, Omni Components and Smith
& Nephew, Inc.
The M2D2 New Venture Competition Program will award up to $100,000 in service awards
(business, engineering, clinical, regulatory, etc.) provided by the program sponsors. Applicants
from across the nation and beyond are invited to participate, but should clearly indicate their
intent to leverage the resources provided as awards in the competition.
Key dates and deadlines:
!"#$ &$' ($) *$+#,-$ ./01$#2#2/+ 34$+#5 6 !$"782+$5
9"+,"-' :
lnfo Sesslon
lnformaLlon sesslon 3:00 aL MlnLz Levln, Cne llnanclal CenLer,
8osLon, MA (no charge)
lor more lnformaLlon emall maryann_plcard[uml.edu
9"+,"-' ;<
$23 appllcaLlon fee
Larly 8lrd appllcaLlon: $23
9"+,"-' =>
AppllcaLlon deadllne
1hls ls Lhe lasL daLe Lo submlL appllcaLlons for Lhe 2013 new
venLure CompeLlLlon. 8egular appllcaLlon fee ($30) applles.
?"-@A B
llnallsLs announcemenL
1he mosL promlslng appllcanLs
are noLlfled and announced as flnallsLs
?"-@A ;<
MaLerlals due
--llnal appllcaLlon due
--ÞosLer due
--ÞresenLaLlon (3 mlnuLe) sllde deck due
M2D2, the Massachusetts Medical Device Development Center, is a joint initiative of the Lowell
and Worcester campuses of the UMass system. Its aim is to help new medical device
entrepreneurs develop products every step of the way, from proof-of-concept to
commercialization. Its affiliated faculty and staff have has assisted more than 100 start-up
companies and entrepreneurs since the program kicked off in the spring of 2007.
Boston Scientific (NYSE: BSX) transforms lives through innovative medical solutions that
improve the health of patients around the world. As a global medical technology leader for more
than 35 years, we advance science for life by providing a broad range of high performance
solutions that address unmet patient needs and reduce the cost of healthcare in the area of
Endoscopy, Cardiac Rhythm Management, Interventional Cardiology, Neuromodulation,
Electrophysiology, Urology and Women’s Health, and Peripheral Interventions.
Mintz Levin provides full-service legal and strategic business services to medical device
companies, including those seeking to grow the kernel of an idea into a thriving business. The
firm supports the complete life cycle of a product and its business: 1) concept & design, 2)
development, 3) testing & approval, and 4) product launch and commercialization. The services
Mintz Levin delivers in order to help clients achieve their goals include patentability analysis,
patent procurement, freedom-to-operate opinions, investment counseling and negotiation,
regulatory representation, compliance counseling, infringement litigation, monetization, and
more.
Smith & Nephew is a global medical technology business dedicated to helping improve people’s
lives. The company has a strong innovation heritage and focus that provides real and tangible
benefits in its core markets of Orthopedic Reconstruction, Sports Medicine, and Trauma surgery.
In the same spirit in which Smith & Nephew approaches disruptive innovation, the company
encourages companies developing medical technologies in these areas to join the M2D2 New
Venture Competition.
Ultimately, the key to innovation for any organization, academic or otherwise, is to build and
establish relationships across a wide spectrum of entrepreneurial groups that are not only
"#$%& '()"#$%& *'
Coachlng sesslons for flnallsLs
+,$-. '
Showcase evenL & posLer sesslons
llnallsLs dellver 3-mlnuLe plLches Lo panel of [udges aL uMass
Lowell, unlverslLy Crosslng, Moloney Pall, 220 ÞawLuckeL SL.,
Lowell MA, posLer sesslons for C&A
+,$-. '/
Wlnners announced & award presenLaLlon
All flnallsLs presenL posLers
Wlnners announced / dellver 3 mlnuLe presenLaLlon aL Lhe
offlces of MlnLz Levln ln 8osLon
technically proficient but also have the same passion for providing better and more economical
surgical solutions.
The M2D2 New Venture Competition Program is interested in receiving a broad range of
applications and is seeking any technologies related to medical devices.
Boston Scientific has identified three areas of interest:
• Additive Manufacturing for Implantable Devices
Solutions will include additive manufacturing methods and/or materials to prepare
implantable medical devices, including those with and without biological material.
• Use of Flexible Electronics to Provide Innovative Implantable Devices
Solutions will include in vivo use of flexible electronics for medical device applications
to treat or diagnose patients.
• Small Form-factor Imaging (65K+ pixels) and Single Pixel Cameras
The solution will provide a small form factor imager with 65K+ pixels or a single pixel
camera in a less than 1mm diameter capable of working under low light conditions along
with a provision for 2 – 3 m signal transmission length.
Smith & Nephew has identified 5 areas of interest where innovation will help address current
and future needs in Orthopedic Reconstruction, Sports Medicine, and Trauma:
• Tools which enable procedure simplification
Solutions would reduce procedural steps, shorten overall procedure time, provide
surgeons with confidence, and/or ensure consistency from procedure to procedure.
• Tissue Sparing Procedures
Solutions would shorten recovery time, decrease the incision/number of portals, and/or
reduce bone removal/soft tissue damage/iatrogenic damage.
• Stabilization of and Integration/Fixation to bone
Solutions would provide high fixation strength both immediately and long-term, and
work regardless of bone density.
• Novel Soft Tissue Repair
Solutions would provide or restore the alignment and functionality of the target tissue
immediately and long term, and be minimally invasive.
• Joint Preservation Solutions
Solutions would provide effective protection of joints, and be minimally invasive.
Solution can be either short-term or long-term/permanent. Early intervention solutions
preferred.
Smith & Nephew is particularly interested in companies developing technologies which could
impact one or more of these areas.
Ventures involving technologies licensed from universities or research labs are encouraged.
Eligibility:
An Applicant must be a duly-organized and existing legal business entity (hereafter referred to as
“Company”), including a partnership, corporation, limited liability company, or joint venture, or
similar business organization or association under the law of the jurisdiction in which the
Company is organized.
The Company must be organized as a for-profit entity.
The Company must be in good standing in the Commonwealth of Massachusetts, and if legally
organized in another state or jurisdiction, must be existing and in good standing in that state or
jurisdiction.
All technology involved in the venture must be advanced enough that it is capable of
demonstration.
Company will be encouraged but not required to locate at M2D2 for at least 6 months following
the conclusion of the competition.
Application Process:
Phase I Judging
Company submits basic information regarding Company and business concept. Documents may
include business plans, financial statements and projections, and any applicable documents as
requested. M2D2 will review initial applications with up to fifteen companies proceeding to the
Phase II Reception and Presentations.
Phase II Reception & Presentations
Company attends reception and presentation event on April 1, 2015 at Moloney Hall, UMass
Lowell, University Crossing, 220 Pawtucket Street, Lowell MA 01854, providing a four-minute
presentation to a Panel of Reviewers followed by one minute Q & A. This event will be open to
the public. Reviewers for this round will be arranged by M2D2 and will include the event
sponsors, Boston Scientific, Mintz Levin and Smith & Nephew. Panel of reviewers score
Company. All New Venture Competition finalists will be invited to the Phase III Final Awards
Announcement and Presentation.
Phase III Final Awards Announcement and Presentation
All New Venture Competition finalists will be invited to the Awards Announcement and
Reception at the Boston office of Mintz Levin, to be held on April 16, 2015. Following the
presentation of awards, winners will be invited to deliver a 5-minute presentation.
Selection and Judging Criteria:
Company will be evaluated based on its chance for market success. The following categories will
be used in evaluating the Company.
1. Value Proposition
2. Operational and Technological Viability
3. Market Opportunity
4. Competitive Advantage
5. Management Team
6. Funding Requirements and Financial Forecast
7. Business Plan
Legal Documentation Required:
The below documents must be made available upon request:
Articles or Certificate of Incorporation (corporation) or Articles of Organization (limited liability
company) or Articles of Limited Partnership, or similar publicly filed organic documents.
By-laws (corporation), Partnership Agreement, or Operating Agreement (limited liability
company).
Certificate(s) of good standing from the Commonwealth of Massachusetts and, if applicable,
from state or country of organization.
Prizes:
The New Venture Competition will award up to $100,000 of in-kind business services: $15,000
from Boston Scientific in the form of general services, $15,000 from Mintz Levin in the form of
legal services, $15,000 from Smith & Nephew in the form of consulting services, $10,000 from
Omni Components in the form of manufacturing services, $5,000 from Massachusetts Life
Sciences Center in the form of Massachusetts-based services, and $40,000 from M2D2 in the
form of medical device development services. All services will be mutually agreed upon with
the winning company or companies.
Final Scoring, selections, and award(s) are made at the sole discretion of the Panel of Reviewers.
Disclosure of Information:
No promise of confidentiality, non-competition or non-disclosure is made by the University of
Massachusetts, reviewers, and sponsors. Any company submitting information for consideration
in this competition acknowledges that its information may be made public, and that any
presentations may be open to any interested parties, including the general public.
Limitation of Liability:
Company releases the Commonwealth of Massachusetts, the University of Massachusetts,
Boston Scientific, Mintz Levin, Smith & Nephew, Inc., and their respective directors, officers,
employees, agents, reviewers, sponsors, and all award suppliers from any and all liability for any
injuries, losses, or damages of any kind resulting from acceptance, possession, or use of any
award or participation in this competition, to the fullest extent permitted by applicable law.
Company agrees to indemnify the Commonwealth of Massachusetts, the University of
Massachusetts, Smith & Nephew, Inc., and their respective sponsors, reviewers, agents or
employees against any claim that Company’s involvement violated any rules or regulations of
the U.S. or any other country as a result of Company's participation.
Company is solely responsible for compliance with any laws, rules and regulations that may be
applicable to participation in the competition or to any awards received.
Company is solely responsible for all (both U.S. and non-U.S.) taxes, withholdings or other
governmental assessments that might be applicable as a result of participating in this
competition.
Governing Law:
The parties agree that this Competition shall be governed, construed, interpreted, and enforced
according to the laws of the Commonwealth of Massachusetts.
doc_938783592.pdf
Brief data in regard to the innovative ideas and entrepreneurial spirit of seed and early stage medical device.
M2D2 New Venture Competition
Call for Applications - Important Information
The University of Massachusetts’ Medical Device Development Center (M2D2) is pleased to
launch the 4
th
Annual M2D2 New Venture Competition, an opportunity designed to showcase
the innovative ideas and entrepreneurial spirit of seed and early-stage medical device companies.
The M2D2 New Venture Competition Program is sponsored in partnership with Boston
Scientific, the Massachusetts Life Sciences Center, Mintz Levin, Omni Components and Smith
& Nephew, Inc.
The M2D2 New Venture Competition Program will award up to $100,000 in service awards
(business, engineering, clinical, regulatory, etc.) provided by the program sponsors. Applicants
from across the nation and beyond are invited to participate, but should clearly indicate their
intent to leverage the resources provided as awards in the competition.
Key dates and deadlines:
!"#$ &$' ($) *$+#,-$ ./01$#2#2/+ 34$+#5 6 !$"782+$5
9"+,"-' :
lnfo Sesslon
lnformaLlon sesslon 3:00 aL MlnLz Levln, Cne llnanclal CenLer,
8osLon, MA (no charge)
lor more lnformaLlon emall maryann_plcard[uml.edu
9"+,"-' ;<
$23 appllcaLlon fee
Larly 8lrd appllcaLlon: $23
9"+,"-' =>
AppllcaLlon deadllne
1hls ls Lhe lasL daLe Lo submlL appllcaLlons for Lhe 2013 new
venLure CompeLlLlon. 8egular appllcaLlon fee ($30) applles.
?"-@A B
llnallsLs announcemenL
1he mosL promlslng appllcanLs
are noLlfled and announced as flnallsLs
?"-@A ;<
MaLerlals due
--llnal appllcaLlon due
--ÞosLer due
--ÞresenLaLlon (3 mlnuLe) sllde deck due
M2D2, the Massachusetts Medical Device Development Center, is a joint initiative of the Lowell
and Worcester campuses of the UMass system. Its aim is to help new medical device
entrepreneurs develop products every step of the way, from proof-of-concept to
commercialization. Its affiliated faculty and staff have has assisted more than 100 start-up
companies and entrepreneurs since the program kicked off in the spring of 2007.
Boston Scientific (NYSE: BSX) transforms lives through innovative medical solutions that
improve the health of patients around the world. As a global medical technology leader for more
than 35 years, we advance science for life by providing a broad range of high performance
solutions that address unmet patient needs and reduce the cost of healthcare in the area of
Endoscopy, Cardiac Rhythm Management, Interventional Cardiology, Neuromodulation,
Electrophysiology, Urology and Women’s Health, and Peripheral Interventions.
Mintz Levin provides full-service legal and strategic business services to medical device
companies, including those seeking to grow the kernel of an idea into a thriving business. The
firm supports the complete life cycle of a product and its business: 1) concept & design, 2)
development, 3) testing & approval, and 4) product launch and commercialization. The services
Mintz Levin delivers in order to help clients achieve their goals include patentability analysis,
patent procurement, freedom-to-operate opinions, investment counseling and negotiation,
regulatory representation, compliance counseling, infringement litigation, monetization, and
more.
Smith & Nephew is a global medical technology business dedicated to helping improve people’s
lives. The company has a strong innovation heritage and focus that provides real and tangible
benefits in its core markets of Orthopedic Reconstruction, Sports Medicine, and Trauma surgery.
In the same spirit in which Smith & Nephew approaches disruptive innovation, the company
encourages companies developing medical technologies in these areas to join the M2D2 New
Venture Competition.
Ultimately, the key to innovation for any organization, academic or otherwise, is to build and
establish relationships across a wide spectrum of entrepreneurial groups that are not only
"#$%& '()"#$%& *'
Coachlng sesslons for flnallsLs
+,$-. '
Showcase evenL & posLer sesslons
llnallsLs dellver 3-mlnuLe plLches Lo panel of [udges aL uMass
Lowell, unlverslLy Crosslng, Moloney Pall, 220 ÞawLuckeL SL.,
Lowell MA, posLer sesslons for C&A
+,$-. '/
Wlnners announced & award presenLaLlon
All flnallsLs presenL posLers
Wlnners announced / dellver 3 mlnuLe presenLaLlon aL Lhe
offlces of MlnLz Levln ln 8osLon
technically proficient but also have the same passion for providing better and more economical
surgical solutions.
The M2D2 New Venture Competition Program is interested in receiving a broad range of
applications and is seeking any technologies related to medical devices.
Boston Scientific has identified three areas of interest:
• Additive Manufacturing for Implantable Devices
Solutions will include additive manufacturing methods and/or materials to prepare
implantable medical devices, including those with and without biological material.
• Use of Flexible Electronics to Provide Innovative Implantable Devices
Solutions will include in vivo use of flexible electronics for medical device applications
to treat or diagnose patients.
• Small Form-factor Imaging (65K+ pixels) and Single Pixel Cameras
The solution will provide a small form factor imager with 65K+ pixels or a single pixel
camera in a less than 1mm diameter capable of working under low light conditions along
with a provision for 2 – 3 m signal transmission length.
Smith & Nephew has identified 5 areas of interest where innovation will help address current
and future needs in Orthopedic Reconstruction, Sports Medicine, and Trauma:
• Tools which enable procedure simplification
Solutions would reduce procedural steps, shorten overall procedure time, provide
surgeons with confidence, and/or ensure consistency from procedure to procedure.
• Tissue Sparing Procedures
Solutions would shorten recovery time, decrease the incision/number of portals, and/or
reduce bone removal/soft tissue damage/iatrogenic damage.
• Stabilization of and Integration/Fixation to bone
Solutions would provide high fixation strength both immediately and long-term, and
work regardless of bone density.
• Novel Soft Tissue Repair
Solutions would provide or restore the alignment and functionality of the target tissue
immediately and long term, and be minimally invasive.
• Joint Preservation Solutions
Solutions would provide effective protection of joints, and be minimally invasive.
Solution can be either short-term or long-term/permanent. Early intervention solutions
preferred.
Smith & Nephew is particularly interested in companies developing technologies which could
impact one or more of these areas.
Ventures involving technologies licensed from universities or research labs are encouraged.
Eligibility:
An Applicant must be a duly-organized and existing legal business entity (hereafter referred to as
“Company”), including a partnership, corporation, limited liability company, or joint venture, or
similar business organization or association under the law of the jurisdiction in which the
Company is organized.
The Company must be organized as a for-profit entity.
The Company must be in good standing in the Commonwealth of Massachusetts, and if legally
organized in another state or jurisdiction, must be existing and in good standing in that state or
jurisdiction.
All technology involved in the venture must be advanced enough that it is capable of
demonstration.
Company will be encouraged but not required to locate at M2D2 for at least 6 months following
the conclusion of the competition.
Application Process:
Phase I Judging
Company submits basic information regarding Company and business concept. Documents may
include business plans, financial statements and projections, and any applicable documents as
requested. M2D2 will review initial applications with up to fifteen companies proceeding to the
Phase II Reception and Presentations.
Phase II Reception & Presentations
Company attends reception and presentation event on April 1, 2015 at Moloney Hall, UMass
Lowell, University Crossing, 220 Pawtucket Street, Lowell MA 01854, providing a four-minute
presentation to a Panel of Reviewers followed by one minute Q & A. This event will be open to
the public. Reviewers for this round will be arranged by M2D2 and will include the event
sponsors, Boston Scientific, Mintz Levin and Smith & Nephew. Panel of reviewers score
Company. All New Venture Competition finalists will be invited to the Phase III Final Awards
Announcement and Presentation.
Phase III Final Awards Announcement and Presentation
All New Venture Competition finalists will be invited to the Awards Announcement and
Reception at the Boston office of Mintz Levin, to be held on April 16, 2015. Following the
presentation of awards, winners will be invited to deliver a 5-minute presentation.
Selection and Judging Criteria:
Company will be evaluated based on its chance for market success. The following categories will
be used in evaluating the Company.
1. Value Proposition
2. Operational and Technological Viability
3. Market Opportunity
4. Competitive Advantage
5. Management Team
6. Funding Requirements and Financial Forecast
7. Business Plan
Legal Documentation Required:
The below documents must be made available upon request:
Articles or Certificate of Incorporation (corporation) or Articles of Organization (limited liability
company) or Articles of Limited Partnership, or similar publicly filed organic documents.
By-laws (corporation), Partnership Agreement, or Operating Agreement (limited liability
company).
Certificate(s) of good standing from the Commonwealth of Massachusetts and, if applicable,
from state or country of organization.
Prizes:
The New Venture Competition will award up to $100,000 of in-kind business services: $15,000
from Boston Scientific in the form of general services, $15,000 from Mintz Levin in the form of
legal services, $15,000 from Smith & Nephew in the form of consulting services, $10,000 from
Omni Components in the form of manufacturing services, $5,000 from Massachusetts Life
Sciences Center in the form of Massachusetts-based services, and $40,000 from M2D2 in the
form of medical device development services. All services will be mutually agreed upon with
the winning company or companies.
Final Scoring, selections, and award(s) are made at the sole discretion of the Panel of Reviewers.
Disclosure of Information:
No promise of confidentiality, non-competition or non-disclosure is made by the University of
Massachusetts, reviewers, and sponsors. Any company submitting information for consideration
in this competition acknowledges that its information may be made public, and that any
presentations may be open to any interested parties, including the general public.
Limitation of Liability:
Company releases the Commonwealth of Massachusetts, the University of Massachusetts,
Boston Scientific, Mintz Levin, Smith & Nephew, Inc., and their respective directors, officers,
employees, agents, reviewers, sponsors, and all award suppliers from any and all liability for any
injuries, losses, or damages of any kind resulting from acceptance, possession, or use of any
award or participation in this competition, to the fullest extent permitted by applicable law.
Company agrees to indemnify the Commonwealth of Massachusetts, the University of
Massachusetts, Smith & Nephew, Inc., and their respective sponsors, reviewers, agents or
employees against any claim that Company’s involvement violated any rules or regulations of
the U.S. or any other country as a result of Company's participation.
Company is solely responsible for compliance with any laws, rules and regulations that may be
applicable to participation in the competition or to any awards received.
Company is solely responsible for all (both U.S. and non-U.S.) taxes, withholdings or other
governmental assessments that might be applicable as a result of participating in this
competition.
Governing Law:
The parties agree that this Competition shall be governed, construed, interpreted, and enforced
according to the laws of the Commonwealth of Massachusetts.
doc_938783592.pdf